tiprankstipranks
BPL Limited (IN:BPL)
:BPL
India Market
Want to see IN:BPL full AI Analyst Report?

BPL Limited (BPL) AI Stock Analysis

1 Followers

Top Page

IN:BPL

BPL Limited

(BPL)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - Gpt-5.6Sol)
Rating:48Neutral
Price Target:
₹49.00
▼(-19.43% Downside)
Action:Reiterated
Date:07/10/26
The score is held down primarily by weak and volatile financial performance, especially the sharp 2026 cash burn and return to losses, despite a conservatively financed balance sheet. Technical indicators provide only modest support (mixed longer-term trend but improving shorter-term signals), while valuation is constrained by negative earnings and no dividend yield data.
Positive Factors
Multi-year Revenue Expansion
The strong revenue increase through 2025 indicates meaningful market expansion and product adoption across healthcare customers. Although 2026 momentum stalled, the established revenue base supports future recovery if execution and product economics improve.
Negative Factors
2026 Revenue Stagnation and Net Loss
The halt in revenue growth alongside a return to losses signals weaker operating momentum and reduced earnings quality. If sustained, this could limit internal funding for innovation, sales expansion, and competitiveness in medical devices.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year Revenue Expansion
The strong revenue increase through 2025 indicates meaningful market expansion and product adoption across healthcare customers. Although 2026 momentum stalled, the established revenue base supports future recovery if execution and product economics improve.
Read all positive factors

BPL Limited (BPL) vs. iShares MSCI India ETF (INDA)

BPL Limited Business Overview & Revenue Model

Company Description
Established in 1963 and headquartered in Bengaluru, India, BPL Limited primarily operates within India, engaging in the manufacturing and distribution of a broad spectrum of electronic goods. The company's diverse product portfolio includes major ...
How the Company Makes Money
BPL primarily makes money by selling medical devices and diagnostic equipment (business-to-business sales to hospitals, clinics, laboratories, and distributors, and business-to-consumer sales through retail/distribution channels for home-use devic...

BPL Limited Financial Statement Overview

Summary
Overall fundamentals are mixed and skew weak. Income Statement quality is low (score 38) with revenue growth stalling in 2026, margin pressure, and a swing back to a net loss. The Balance Sheet is a relative strength (score 72) with low leverage and solid equity, but Cash Flow is the key risk (score 22) due to sharp 2026 operating/FCF deterioration and inconsistent cash generation.
Income Statement
38
Negative
Balance Sheet
72
Positive
Cash Flow
22
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue802.65M781.24M783.59M664.25M522.16M382.07M
Gross Profit212.65M166.00M260.54M336.90M215.40M115.52M
EBITDA34.07M46.91M46.17M194.52M155.31M107.85M
Net Income-148.22M-85.50M942.00K132.91M50.91M129.50M
Balance Sheet
Total Assets7.14B7.14B6.13B6.16B5.99B5.36B
Cash, Cash Equivalents and Short-Term Investments31.05M28.41M15.24M97.70M15.91M6.43M
Total Debt3.14B1.06B101.12M300.93M228.55M138.27M
Total Liabilities3.43B3.38B2.29B2.32B2.28B2.35B
Stockholders Equity2.37B2.41B2.49B2.49B2.36B1.66B
Cash Flow
Free Cash Flow-817.71M-875.04M152.95M-19.57M18.40M-8.90M
Operating Cash Flow-815.70M-872.08M159.34M42.92M62.59M-6.61M
Investing Cash Flow-5.56M-9.32M515.25M-77.97M42.88M36.28M
Financing Cash Flow820.53M880.01M-2.94M61.56M-101.67M-38.76M

BPL Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price60.82
Price Trends
50DMA
54.25
Negative
100DMA
53.92
Negative
200DMA
56.08
Negative
Market Momentum
MACD
-1.19
Negative
RSI
47.98
Neutral
STOCH
36.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BPL, the sentiment is Neutral. The current price of 60.82 is above the 20-day moving average (MA) of 51.79, above the 50-day MA of 54.25, and above the 200-day MA of 56.08, indicating a bearish trend. The MACD of -1.19 indicates Negative momentum. The RSI at 47.98 is Neutral, neither overbought nor oversold. The STOCH value of 36.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:BPL.

BPL Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₹2.38B12.85-13.87%0.60%
69
Neutral
₹900.63B46.570.06%14.34%60.04%
69
Neutral
₹2.43B8.940.82%35.25%30.99%
58
Neutral
₹2.44B20.040.67%-2.76%32.21%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
48
Neutral
₹2.53B-17.182.03%-40.01%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:BPL
BPL Limited
51.93
-26.38
-33.69%
IN:DIXON
Dixon Technologies (India) Ltd.
14,729.40
-1,928.14
-11.58%
IN:DPWIRES
DP Wires Ltd.
155.20
-65.49
-29.68%
IN:KALYANIFRG
Kalyani Forge Limited
683.65
34.58
5.33%
IN:VETO
Veto Switchgears & Cables Ltd.
127.80
18.32
16.73%
IN:VIDEOIND
Videocon Industries Limited

BPL Limited Corporate Events

BPL Limited Secures SEBI Compliance Certificate for June Quarter
Jul 10, 2026
BPL Limited has notified the Bombay Stock Exchange and National Stock Exchange that it has obtained a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026. ...
BPL Limited Launches Fully Digital Postal Ballot for Shareholder Approvals
Jul 7, 2026
BPL Limited has notified stock exchanges that it has published a postal ballot notice in leading English and Malayalam newspapers, in line with SEBI listing regulations. The notice confirms that shareholder approval for specified business items wi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 10, 2026